Showing results (71-80 of 90) with videos related to
Sort By:
Pageof 9
Molecular Neurodegeneration|July 28, 2009
Conditional transgenic mice expressing C-terminally truncated human alpha-synuclein (alphaSyn119) exhibit reduced striatal dopamine without loss of nigrostriatal pathway dopaminergic neuronsJoão Paulo L Daher, Mingyao Ying, Rebecca Banerjee, et al.Human Molecular Genetics|November 1, 2016
Human R1441C LRRK2 regulates the synaptic vesicle proteome and phosphoproteome in a Drosophila model of Parkinson's diseaseMd Shariful Islam, Hendrik Nolte, Wright Jacob, et al.Journal of Neuropathology and Experimental Neurology|March 18, 2011
Localization of MAP1-LC3 in vulnerable neurons and Lewy bodies in brains of patients with dementia with Lewy bodiesShinji Higashi, Darren J Moore, Michiko Minegishi, et al.Proceedings of the National Academy of Sciences of the United States of America|February 7, 2009
CHIP regulates leucine-rich repeat kinase-2 ubiquitination, degradation, and toxicityHan Seok Ko, Rachel Bailey, Wanli W Smith, et al.The Journal of Neuroscience : the Official Journal of the Society for Neuroscience|March 28, 2008
The chaperone activity of heat shock protein 90 is critical for maintaining the stability of leucine-rich repeat kinase 2Lizhen Wang, Chengsong Xie, Elisa Greggio, et al.Journal of Neuropathology and Experimental Neurology|August 15, 2009
Abnormal localization of leucine-rich repeat kinase 2 to the endosomal-lysosomal compartment in lewy body diseaseShinji Higashi, Darren J Moore, Ryoko Yamamoto, et al.Biorxiv : the Preprint Server for Biology|April 25, 2024
Single molecule array measures of LRRK2 kinase activity in serum link Parkinson's disease severity to peripheral inflammationYuan Yuan, Huizhong Li, Kashyap Sreeram, et al.Molecular Neurodegeneration|June 11, 2024
Single molecule array measures of LRRK2 kinase activity in serum link Parkinson's disease severity to peripheral inflammationYuan Yuan, Huizhong Li, Kashyap Sreeram, et al.The Journal of Biological Chemistry|February 9, 2012
α-Synuclein in central nervous system and from erythrocytes, mammalian cells, and Escherichia coli exists predominantly as disordered monomerBruno Fauvet, Martial K Mbefo, Mohamed-Bilal Fares, et al.Movement Disorders : Official Journal of the Movement Disorder Society|May 8, 2023
Defining the Riddle in Order to Solve It: There Is More Than One "Parkinson's Disease"Tiago F Outeiro, Roy N Alcalay, Angelo Antonini, et al.Pageof 9